Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targin for Pain and Constipation in Spinal Cord Injury
NCT03179475Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- Sep 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxycodone in chronic pain and opioid-induced constipation (OIC), sponsored by University of British Columbia. Primary endpoint: Change in management of pain related to spinal cord injury at 8 weeks. Started Sep 2019; status: completed.
02
Drugs
oxycodone
03
Conditions
chronic painopioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT03179475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03179475.